CVS Health operates a network of subsidiaries designed to obscure their operations, avoid oversight, and maximize profits. From Cordavis to Zinc Health Services, these entities create unnecessary middlemen and layers of confusion that allow CVS to extract additional fees while shielding CVS from scrutiny over its harmful practices.
CVS's Corporate Pickpockets
Cordavis
A Power Grab Disguised as Savings
Under the guise of "lowering drug costs," CVS launched an Irish subsidiary called Cordavis to "co-produce" biosimilar medications. But this move isn't about helping patients — it's about creating a new fee stream that boosts CVS's profits.
Zinc Health Services
The Financial Black Box
Zinc Health Services is one of CVS's least visible but most strategically important subsidiaries. Officially structured as a group purchasing organization (GPO), Zinc operates in the shadows, acting as the entity that negotiates and collects drug manufacturer rebates on behalf of CVS Caremark.
Want to take action against CVS's anti-competitive practices?